The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review

BACKGROUND: Hormone Therapy (HT) is recommended for most women with HR-positive primary breast cancer. When taken as intended, HT reduces breast cancer recurrence by 40% and mortality by one-third. The recommended duration of treatment ranges from 5 to 10 years depending on risk of recurrence and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleming, Leanne, Agnew, Sommer, Peddie, Nicola, Crawford, Megan, Dixon, Diane, MacPherson, Iain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130570/
https://www.ncbi.nlm.nih.gov/pubmed/35609380
http://dx.doi.org/10.1016/j.breast.2022.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130570/
https://www.ncbi.nlm.nih.gov/pubmed/35609380
http://dx.doi.org/10.1016/j.breast.2022.04.010

Ejemplares similares